Goldman Sachs stock rises after hours as Solomon adds seven AWM leaders to top committee
27 January 2026
2 mins read

Goldman Sachs stock rises after hours as Solomon adds seven AWM leaders to top committee

New York, January 26, 2026, 18:28 (EST) — After-hours trading

Goldman Sachs shares climbed $12.47, or 1.4%, to $931.86 in after-hours trading Monday. The move followed the bank’s announcement that it added seven Asset & Wealth Management leaders to its Management Committee. CEO David Solomon described growth in the unit as a “core strategic objective” and said the new members will help develop a “global, scaled AWM platform,” according to a company statement. 1

Goldman is pushing more aggressively toward stable fee income while keeping its dealmaking and trading engines humming. Earlier this month, the bank posted record equities trading revenue and reported quarterly management fees of $3.09 billion. Assets under supervision rose to $3.61 trillion. “The world is set up at the moment to be incredibly constructive in 2026 for M&A and capital markets,” Solomon said during the earnings call. 2

Rates have reclaimed center stage. Bond investors are now bracing for the Federal Reserve to hit pause on rate cuts, with futures showing roughly 44 basis points of easing priced in for 2026, according to Reuters. Tony Rodriguez, Nuveen’s head of fixed income strategy, weighed in, saying “a pause makes a lot of sense.”

Goldman Sachs also announced it will redeem all outstanding depositary shares linked to three series of fixed-rate reset non-cumulative preferred stock on Feb. 10. The company plans to pay $1,000 per depositary share, plus any accrued and unpaid dividends up to that date. Dividends will cease accruing after the redemption date. 3

Goldman’s rise followed strength across major U.S. financials. Morgan Stanley shares jumped 1.5% in after-hours trading, JPMorgan added 1.1%, and Bank of America edged up 0.6%. The Financial Select Sector SPDR Fund also gained roughly 0.7%.

A recent filing revealed GS Finance Corp is pitching an “autocallable” index-linked note maturing in 2029, backed by The Goldman Sachs Group Inc. This structured product can be called early if certain triggers are hit, but investors face significant risks if the lowest-performing linked asset tanks. The preliminary pricing supplement cautioned that investors “could lose” their entire investment. 4

For equity investors, the management committee selections signal a clear tilt toward businesses generating steady fees — private credit, wealth management, alternatives — steering clear of the volatility tied to trading and underwriting cycles. The impact might not show up next quarter, but it reveals where the real influence is moving inside the firm.

The stock’s been riding the rate narrative lately, not organizational changes. A Fed tone shift or a sudden jump in yields can easily drown out company-specific news, especially for banks that are central to market movements.

One risk for bulls: the recent buzz over deal flow and market action could fade as 2026 progresses. Should volatility drop and corporate boards hold back, advisory and trading revenues might dip quickly. Investors often react harshly, even if the long-term strategy remains solid.

The next major hurdle comes Wednesday with the Federal Reserve’s decision. The policy statement drops at 2:00 p.m. ET, followed by Chair Jerome Powell’s press conference at 2:30 p.m. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Eli Lilly stock price slips after-hours as hospitals push back on new 340B data rule
Previous Story

Eli Lilly stock price slips after-hours as hospitals push back on new 340B data rule

GE Aerospace stock edges up after NASA-backed hybrid-electric engine test milestone
Next Story

GE Aerospace stock edges up after NASA-backed hybrid-electric engine test milestone

Go toTop